arrow
S

Sheldon E. Litwin

medical university of south carolina and the ralph h. johnson veterans affairs medical center
H指数:60
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Heart Failure Duration, Cardiac Remodeling, Dysfunction, and Hemodynamic Severity in HFpEF and HFmrEF

HFpEF和HFmrEF患者中心衰持续时间、心脏重构、功能障碍及血流动力学严重程度

2026-06-100
PRE
Long-term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trials (Vol 278,pg 106, 2024)
2025-12-010
OAAI
Epicardial Adipose Tissue, Functional Status, and Invasive Hemodynamics in Heart Failure With Preserved Ejection Fraction

Crum, Y.; van Veldhuisen, D.J.; Shah, S.J.; Mylavarapu, U.; Hu, M.; Komtebedde, J.; Lobeek, M.; Hoendermis, E.S.; Litwin, S.E.; Solomon, S.D.; 等. 心外膜脂肪组织、功能状态和侵入性血流动力学在射血分数保留的心力衰竭中的作用. JACC Adv. 2025, 4, 102185. [Google Scholar] [CrossRef]

2025-12-013
OAAI
Mechanistic Basis for Differential Effects of Interatrial Shunt Treatment in HFrEF vs HFpEF: The RELIEVE-HF trial

心房间分流治疗在HFrEF与HFpEF中差异化效应的机制基础:RELIEVE-HF试验

2025-09-150
OAAI
Endovascular Ablation of the Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction The REBALANCE-HF Randomized Clinical Trial
2024-12-012
PRE
Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trials
2024-12-010
PRE